153 related articles for article (PubMed ID: 35304708)
1. The Historical Relationship Between Meis1 and Leukemia.
Meriç N; Kocabaş F
Adv Exp Med Biol; 2022; 1387():127-144. PubMed ID: 35304708
[TBL] [Abstract][Full Text] [Related]
2. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis.
Meriç N; Albayrak E; Gülbaş Z; Kocabaş F
Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585
[TBL] [Abstract][Full Text] [Related]
3. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
Wong P; Iwasaki M; Somervaille TC; So CW; Cleary ML
Genes Dev; 2007 Nov; 21(21):2762-74. PubMed ID: 17942707
[TBL] [Abstract][Full Text] [Related]
4. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
[TBL] [Abstract][Full Text] [Related]
5. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
6. TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
Willer A; Jakobsen JS; Ohlsson E; Rapin N; Waage J; Billing M; Bullinger L; Karlsson S; Porse BT
Leukemia; 2015 May; 29(5):1018-31. PubMed ID: 25349154
[TBL] [Abstract][Full Text] [Related]
7. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
8. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
[TBL] [Abstract][Full Text] [Related]
9. Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memory.
Stahlhut M; Ha TC; Takmakova E; Morgan MA; Schwarzer A; Schaudien D; Eder M; Schambach A; Kustikova OS
Sci Rep; 2021 Mar; 11(1):5294. PubMed ID: 33674652
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
[TBL] [Abstract][Full Text] [Related]
12. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
[TBL] [Abstract][Full Text] [Related]
13. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
Wang GG; Pasillas MP; Kamps MP
Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
[TBL] [Abstract][Full Text] [Related]
14. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
[TBL] [Abstract][Full Text] [Related]
15. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.
Rosales-Aviña JA; Torres-Flores J; Aguilar-Lemarroy A; Gurrola-Díaz C; Hernández-Flores G; Ortiz-Lazareno PC; Lerma-Díaz JM; de Celis R; González-Ramella Ó; Barrera-Chaires E; Bravo-Cuellar A; Jave-Suárez LF
J Exp Clin Cancer Res; 2011 Dec; 30(1):112. PubMed ID: 22185299
[TBL] [Abstract][Full Text] [Related]
16.
Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
[No Abstract] [Full Text] [Related]
17. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
Morgado E; Albouhair S; Lavau C
Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression.
Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM
Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649
[TBL] [Abstract][Full Text] [Related]
19. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
[No Abstract] [Full Text] [Related]
20. Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.
Thorne RM; Milne TA
Haematologica; 2015 Jul; 100(7):850-3. PubMed ID: 26130510
[No Abstract] [Full Text] [Related]
[Next] [New Search]